Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff
1 other identifier
observational
37
1 country
1
Brief Summary
This is a clinical investigation study. It will verify the long-term safety and performance of the Pitch-Patch when implanted to reinforce partially repairable rotator cuff tears and used as described by the manufacturer's instructions. The medical device in this study is already on the market and is manufactured by Xiros Ltd. The Pitch-Patch is a single-use polyester prosthesis available in two sizes (30x20mm and 35x25mm). It is reinforced around the perimeter and around each eyelet to provide strength and stability to the device and repair. The study will collect data on patients who meet the entry criteria and have received the device. This is a single-armed study, meaning all patients will have a Pitch-Patch. The total length of the study is expected to be 3 years. A minimum of 37 patients will be enrolled into the study. Patients will be enrolled at a study specific follow up visit 2-2.5 years after implant, and data for baseline, procedure, and other time points prior to 2 years (3month, 6month, and 1 year post surgery) will be collected retrospectively from medical records if available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
May 15, 2026
May 1, 2026
3.5 years
May 25, 2023
May 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Constant Murley Score (CMS)
The primary performance endpoint is the change in the CMS from baseline (if available) and between post-surgery timepoints up to at least 2 years after surgery. CMS comprises of 4 parts: Pain reported by the patient (max 15 points), activities of daily living reported by patient (max 20 points), range of movement assess by the examiner (max 40 points), and strength assessed by the examiner (max 25 points). Scores range from 0 to 100. Better functioning shoulders will have a greater number of points, up to a maximum of 100 points.
2 years
Device Related or Procedure Related Adverse Events
Device related and/ or procedure related adverse events up to at least 2 years after surgery
2 years
Secondary Outcomes (6)
Re-tear Rate
2 years
Constant Murley Score (subscale)
2 years
Normal Daily Work/ Normal Recreational Activities
2 years
Tegner Score
2 years
Subjective Shoulder Value
2 years
- +1 more secondary outcomes
Interventions
Pitch-Patch device used for rotator cuff augmentation/ reinforcement.
Eligibility Criteria
Rotator cuff tear treated with Pitch-Patch for augmentation or reinforcement of the rotator cuff.
You may qualify if:
- Patient has been treated using a Pitch-Patch device for augmentation or reinforcement of the rotator cuff 2-2.5years prior to enrolment.
- Patient has a baseline Constant Murley Score (CMS), assessed within 30 days prior to implantation of the device.
- Patient must be 16 years old or above.
- Patient is willing to participate in the study, and having been informed of the nature of the study, has provided written informed consent as approved by the Ethics Committee (EC).
You may not qualify if:
- \- The Pitch-Patch has been used outside its intended use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xiros Ltdlead
Study Sites (1)
Reading Shoulder Unit
Reading, RG1 6UZ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2023
First Posted
June 15, 2023
Study Start
May 1, 2026
Primary Completion (Estimated)
November 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
May 15, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share